---
figid: PMC5437116__fnbeh-11-00093-g0001
figtitle: 'Commentary: Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor
  Impairment in a Rat Model of Parkinsonism'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Derris elliptica
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5437116
filename: fnbeh-11-00093-g0001.jpg
figlink: /pmc/articles/PMC5437116/figure/F1/
number: F1
caption: 'Schematic representation of simplified diagram demonstrating the connections
  within the basal circuitry, and changes in the activity of basal ganglia nuclei
  associated with the mechanism of symptomatic anti-Parkinsonian activity of A2A receptor
  antagonists. The striatum is connected to the thalamus through two pathways: indirect
  (striatum/globus pallidus pars externa-GPe/subthalamic-STN/nigral) and direct (globus
  pallidus pars interna complex-GPi/substantia nigra pars reticulate-SNr) pathways.
  In the normal state (A), dopamine of the substantia nigra pars compacta (SNc) acts
  on inhibitory D2 receptors of the indirect pathway and on stimulatory D1 receptors
  of the direct pathway. In (B), altered pathways are seen in Parkinson''s disease
  caused by depletion of dopamine. In (C), the A2A receptors modulate the indirect
  basal ganglia pathway due the co-localization with the dopaminergic D2 receptors
  (A2A–D2).'
papertitle: 'Commentary: Adenosine A2A Receptor Blockade Prevents Rotenone-Induced
  Motor Impairment in a Rat Model of Parkinsonism.'
reftext: Marina F. de Souza, et al. Front Behav Neurosci. 2017;11:93.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7708455
figid_alias: PMC5437116__F1
figtype: Figure
redirect_from: /figures/PMC5437116__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5437116__fnbeh-11-00093-g0001.html
  '@type': Dataset
  description: 'Schematic representation of simplified diagram demonstrating the connections
    within the basal circuitry, and changes in the activity of basal ganglia nuclei
    associated with the mechanism of symptomatic anti-Parkinsonian activity of A2A
    receptor antagonists. The striatum is connected to the thalamus through two pathways:
    indirect (striatum/globus pallidus pars externa-GPe/subthalamic-STN/nigral) and
    direct (globus pallidus pars interna complex-GPi/substantia nigra pars reticulate-SNr)
    pathways. In the normal state (A), dopamine of the substantia nigra pars compacta
    (SNc) acts on inhibitory D2 receptors of the indirect pathway and on stimulatory
    D1 receptors of the direct pathway. In (B), altered pathways are seen in Parkinson''s
    disease caused by depletion of dopamine. In (C), the A2A receptors modulate the
    indirect basal ganglia pathway due the co-localization with the dopaminergic D2
    receptors (A2A–D2).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - da
  - Eef1a2
  - Gpi1
  - Pd
  - Adra2a
  - Sema6a
  - di
  - EEF1A2
  - GYPE
  - GPI
  - GNPDA1
  - IGKV2D-29
  - SEMA6A
  - KRT5
  - nAChRalpha2
  - AP-2alpha
  - Ada
  - stnA
  - stnB
  - Snr1
  - Pgi
  - mod(mdg4)
  - pd
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - GABA-B-R1
  - Rdl
  - Gabat
  - levy
  - COX6AL2
  - tt
  - Dd
  - vn
  - Adenosine
  - caffeine
  - Dopamine
  - GABA
  - Glutamate
---
